Drug Database
Back to search

Belgium· BE-AMP-SAM263751-00

Daphne 2 mg - 0.035 mg

A cyproteron und estrogen product containing cyproterone acetate, registered in Belgium by Ceres Pharma. The same ATC class is registered in 11 of our 19 countries.

ATC G03HB01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedDaphne 2 mg - 0.035 mgATCG03HB01REGISTER NO.BE-AMP-SAM263751-00PACKS LISTED4CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cyproterone acetateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cyproteron und estrogen is registered in 11 of 19 countries.

Countries holding a registration under ATC G03HB01 (cyproteron und estrogen), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search cyproteron und estrogen products by name

Cyproteron und estrogen · ATC G03HB01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Cyproterone acetate
Manufacturer
Ceres Pharma
Country
Belgium (BE)
ATC code
G03HB01
ATC class
Cyproteron und Estrogen
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 4

2 priced
  • be_apb
    2112027
  • be_apb
    0781377
  • be_apb
    2232973
    EUR 21.27
  • be_apb
    2394062
    EUR 37.46

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

32 interactions on record for cyproteron und estrogen.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cyproteron und estrogen against other medicinesHow interaction checks work

Cyproteron und estrogen · interactions on record

32 records

32 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Cyproteron und estrogen in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cyproteron und estrogen products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Androcur
  • Bulgaria · Андрокур, Андрокур Депо
  • Czechia · Androcur, Androcur Depot
  • Germany · Androcur, Androcur-Depot
  • Denmark · Androcur Depot
  • Estonia · Androcur
  • Spain · Androcur
  • France · Acetate De Cyproterone Arrow, Androcur
  • United Kingdom (Northern Ireland) · Androcur, Cyprostat
  • Greece · Androcur
  • Croatia · Androcur
  • Hungary · Androcur
  • Ireland · Androcur
  • Italy · Androcur
  • Lithuania · Androcur
  • Luxembourg · Androcur
  • Latvia · Androcur
  • Netherlands · Androcur, Androcur 50
  • Norway · Androcur
  • Poland · Androcur
  • Portugal · Androcur, Androcur Depot
  • Romania · Androcur
  • Sweden · Androcur
  • Slovenia · Androcur
  • Slovakia · Androcur, Androcur Depot

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/479c6fd9-6870-431c-b05d-4ae0c8120323
GET /v1/drugs/479c6fd9-6870-431c-b05d-4ae0c8120323?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Daphne 2 mg - 0.035 mg",
  "name_fr": "Daphne 2 mg - 0.035 mg",
  "name_nl": "Daphne 2 mg - 0.035 mg",
  "amp_code": "SAM263751-00",
  "strengths": [
    "2.0000",
    "0.0350",
    "68.8000",
    "1.5000"
  ],
  "pack_count": 4,
  "substances": [
    "Cyproterone acetate",
    "Ethinylestradiol",
    "Lactose Monohydrate",
    "Sodium Starch Glycolate (Type A)"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Cyproterone and Estrogen",
  "authorisation_numbers": [
    "BE263751"
  ]
}
API referenceMCP serverPlans

See everything about cyproteron und estrogen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console